Warfarin, which consists of a racemic mixture of S-and Renantiomer, has been used as an anticoagulant agent. The anticoagulant activity of S-warfarin is 3-5 times greater than that of R-warfarin.
Ethanol is widely used as a pharmaceutical excipient for the solubilization of many hydrophobic drugs. Various drugs can pharmacokinetically or pharmacodynamically interact with alcohol. 8) Our previous study suggested that ethanol changes the binding of warfarin enantiomer to human serum albumin stereoselectively. 9) Acute intoxication by alcohol reduces the metabolism of warfarin by CYPs, causing increased anticoagulant effects, and leading to a risk of hemorrhage. 10) Conversely, chronic alcohol ingestion might enhance metabolic enzyme activity, leading to a decrease in the anticoagulant effects of warfarin. Hamitouche et al. 11) showed that CYP2C9, as well as other CYPs such as CYP2E1, CYP1A2, and CYP3A4, is also able to metabolize ethanol, and indicated that these CYPs have a low affinity for ethanol for its metabolization. The apparent K m value determined for ethanol oxidation by various CYPs was around 10 mM.
11)
Therefore, it is possible that ethanol affects the metabolism of other substrates by CYP2C9. Few studies on the effect of ethanol on warfarin metabolism by human CYP2C9 in vitro have been reported. The non-significant metabolic interaction of diclofenac (15 mM) with ethanol by CYP2C9 has been reported. 12) However, the effect of ethanol on the metabolism of diclofenac at lower concentrations by CYP2C9 has not been examined. In this paper, we have examined the effect of ethanol on the metabolism of S-warfarin and diclofenac by recombinant CYP2C9.1 microsomes (CYP2C9.1).
MATERIALS AND METHODS
Materials S-(Ϫ)-Warfarin, diclofenac sodium, ethanol, naproxen, NADP ϩ , glucose-6-phosphate, MgCl 2 · 6H 2 O, and glucose-6-phosphate dehydrogenase were purchased from Wako Pure Chemical Ind. (Osaka, Japan). 4Ј-Hydroxydiclofenac was purchased from Sigma-Aldrich (MO, U.S.A.). 7-Hydroxywarfarin and human CYP2C9.1ϩP450 reductase microsomes derived from baculovirus expression systems were purchased from BD Gentest (MA, U.S.A.). All other chemicals and solvents were of analytical grade or higher.
Inhibition Study According to the method of Iwakawa et al., 13) a metabolic inhibition study was performed. The time of incubation and concentration of microsomal protein in the study were determined to be in a linear range for the rate of formation of 7-hydroxywarfarin or 4Ј-hydroxydiclofenac. Initially, S-warfarin or diclofenac (final concentration: 1-10 mM) in 50 mM Tris-HCl (pH 7.4) with or without ethanol (0.05-3.0 vol%; 8.5-510 mM) and an NADPH-regenerating system (NADP ϩ : 0.5 mM, glucose-6-phosphate: 2 mM, MgCl 2 : 4 mM, glucose-6-phosphate dehydrogenase: 1 U/ml) were preincubated for 10 min at 37°C, and then CYP2C9.1 (6.5 nM) was added to the preincubated mixture at 37°C. The total incubation volume was 0.25 ml. After 30 min, the incubation was terminated by the addition of acetonitrile (0.25 ml) containing 2.7 mM naproxen as an internal standard. The mixture was centrifuged for 5 min at 18620ϫg at 4°C. An aliquot of the supernatant was used for the analysis of warfarin metabolites or diclofenac metabolites by the HPLC system. Incubations were performed in duplicate.
HPLC Analysis According to a slightly modified method reported by Iwakawa et al. 13 ) the contents of 7-hydroxywarfarin enantiomers and 4Ј-hydroxydiclofenac were analyzed by HPLC using a chiral column. HPLC analyses were performed using a Shimadzu SCL-10Avp system controller, a Shimadzu LC-10ADvp pump, a Shimadzu SIL10ADvp auto-injector, a Shimadzu SPD-10Avp variable wavelength UV detector, a Shimadzu RF-10AXL fluorescence detector (Kyoto, Japan), and a Daicel Chiralcel OD-RH column (4.6 mm i.d. ϫ150 mm, 5 mm) (Tokyo, Japan). The mobile phase consisted of 0.1 M sodium dihydrogen phosphate pH 2.0/acetonitrile (65/35 by volume). The flow rate was 0.5 ml/min. The column temperature was maintained at 40°C. The injected volume for the S-warfarin or diclofenac sample was 25 ml or 50 ml, respectively. For detecting 7-hydroxywarfarin, the effluent was monitored at 312 nm with a UV detector and at an excitation wavelength of 320 nm and an emission wavelength of 415 nm with a fluorescence detector. For detecting 4Ј-diclofenac, the UV detector was set at 280 nm.
14)
Statistical Analysis Data are expressed as the mean values and standard deviation. Analysis of variance (ANOVA) was used to test the significance of differences among groups. Significance regarding differences in the means among groups was determined by Tukey's test. Significance was defined as pϽ0.05.
RESULTS
The ethanol concentration to inhibit S-warfarin metabolism was lower than that to inhibit diclofenac metabolism (Fig. 1) . The inhibitory effect of ethanol on the metabolism of 1 or 10 mM S-warfarin was observed by increasing the ethanol concentration. The metabolism of 1 mM diclofenac was also decreased by increasing the ethanol concentration. However, ethanol only slightly inhibited the rate of metabolism of 10 mM diclofenac.
Ethanol non-significantly affected the K m value of S-warfarin metabolism (Table 1) . On the contrary, the V max and V max /K m (apparent intrinsic clearance) values of S-warfarin metabolism decreased linearly with an increasing ethanol concentration. The V max and V max /K m values in the presence of 1 vol% (170 mM) ethanol were about 75 and 85%, respectively, being lower than those of the control. These results suggest that the inhibition profile of ethanol on 7-hydroxylation metabolism of the S-warfarin enantiomer by CYP2C9.1 shows an allosteric phenomenon.
Non-significant changes in the V max value of diclofenac metabolism were observed up to 3.0 vol% (510 mM) of ethanol. The K m value of diclofenac metabolism was increased from 3.3Ϯ0.6 to 5.5Ϯ0.7 mM in the presence of 3.0 vol% (510 mM) ethanol (pϽ0.05). The V max /K m value of diclofenac metabolism was decreased with an increasing ethanol concentration. The V max /K m value (1.2Ϯ0.1 ml/min/nmol P450) with 3.0 vol% (510 mM) ethanol was about 40% lower than the V max / K m value (2.0Ϯ0.1 ml/min/nmol P450) of the control (Table  2 ). These results suggest that ethanol inhibits 4Ј-hydroxylation of diclofenac by CYP2C9.1 in a competitive manner.
DISCUSSION
Acute intoxication by alcohol reduces the metabolism of warfarin by cytochrome P450, leading to increased anticoagulant effects and the risk of hemorrhage. 10) Practically, an increased antithrombotic effect of warfarin by ethanol was induced by protein-binding interactions and decreased warfarin metabolism through the cytochrome P450 enzyme system. 15) Our previous study suggested that ethanol changes the binding of warfarin enantiomer to human serum albumin stereoselectively. 9) However, that study was performed 2.9% (500 mM) of ethanol. The present study indicated that ethanol affected warfarin metabolism by CYP2C9.1. The 7-hydroxylation metabolism of S-warfarin was inhibited by as low as 0.1 vol% (17 mM) ethanol, which suggest the inhibition of Swarfarin metabolism by CYP2C9.1 is more sensitive to ethanol than that of S-warfarin binding to human serum albumin.
Our findings showed that S-warfarin 7-hydroxylation and diclofenac 4Ј-hydroxylation by CYP2C9.1 were inhibited by ethanol, whereas Busby et al. 12) reported that CYP2C9 (diclofenac 4Ј-hydroxylase activity) was not inhibited by ethanol (0.3-3 vol%; 51-510 mM). Their study was performed using a high concentration of diclofenac (15 mM). In our study performed with a relatively low concentration of diclofenac (1-10 mM), which is comparable to the blood concentration during medication, ethanol inhibited diclofenac 4Ј-hydroxylation by CYP2C9.1, which may be ex- plained by the differences in experimental conditions. The inhibitory effect of ethanol on S-warfarin metabolism by CYP2C9 differed from that on diclofenac metabolism. SWarfarin 7-hydroxylation by CYP2C9.1 was inhibited by ethanol at as low as 0.1 vol% (17 mM) allosterically. The V max value of S-warfarin 7-hydroxylation decreased linearly with an increasing ethanol concentration, although the K m value was unaffected. On the contrary, diclofenac 4Ј-hydroxylation by CYP2C9.1 was inhibited by 3 vol% (510 mM) ethanol competitively. The K m value of diclofenac 4Ј-hydroxylation was increased in the presence of 3.0 vol% (510 mM) ethanol and non-significant changes in the V max value were observed up to 3.0 vol% (510 mM) of ethanol. Since it was reported that ethanol denatures globular proteins, 16) the allosteric inhibition of S-warfarin metabolism by ethanol may result in structural changes in the binding site of CYP2C9.1. In contrast, structural changes of the binding site brought about by ethanol at a low concentration did not alter the metabolism of diclofenac, a planar structure compound. Busby et al. suggested that the inhibitory effects of solvents are substratedependent for a given CYP.
12) The substrate-dependent inhibitory effect of acetonitrile was also observed in the metabolism of various drugs by CYP2C9.
17) The present study suggests that the inhibitory effects of ethanol on drug metabolism are substrate-dependent for CYP2C9.1. Further experiments are required to define the extent of this substrate selectivity.
